natgillin/translations-raw huggingface dataset:
Among patients with plaque psoriasis who received Enbrel, significant responses relative to placebo were apparent at the time of the first visit (2 weeks) and were maintained through 24 weeks of therapy. 
Med bolniki s psoriazo v plakih, ki so dobivali zdravilo Enbrel, je bil pomemben odziv v primerjavi s placebom opazen na prvem pregledu (po 2 tednih) in se je ohranil skozi 24 tednov zdravljenja.
Enbrel was administered at doses of 25 mg once a week, 25 mg twice a week or 50 mg twice a week for 6 consecutive months. 
Zdravilo Enbrel so dobivali 6 mesecev zapored v odmerkih 25 mg enkrat na teden, 25 mg dvakrat na teden ali 50 mg dvakrat na teden.
At week 12, more patients randomised to Enbrel had positive efficacy responses (e.g., PASI 75) than those randomised to placebo. 
V 12. tednu je imelo pozitivne odzive glede učinkovitosti (npr. PASI 75) več bolnikov v skupini z zdravilom Enbrel kot v skupini s placebom.
In an analysis in which all patients who dropped out of the study for any reason were considered to have progressed, the percentage of patients without progression (TSS change ≤ 0.5) at 
Opravljena je bila analiza, v kateri so vse bolnike, ki so iz kakršnegakoli razloga izpadli iz študije, obravnavali, kot da jim je bolezen napredovala.
Radiographic Progression: Comparison of Enbrel vs Methotrexate vs Enbrel in Combination with Methotrexate in Patients with RA of 6 Months To 20 Years Duration (12 Month Results) 
Radiografsko napredovanje: primerjava med zdravilom Enbrel, metotreksatom in kombinacijo zdravila Enbrel in metotreksata pri bolnikih z RA, ki je trajal 6 mesecev do 20 let (rezultati pri 12 mesecih)
A total of 2 malignancies were reported in clinical studies of approximately 2 years duration involving 240 Enbrel-treated psoriatic arthritis patients. 
V kliničnih študijah z zdravilom Enbrel, ki so trajale približno 2 leti in so vključevale 240 bolnikov s psoriatičnim artritisom, so poročali o 2 primerih malignega obolenja.
• Chickenpox: Tell your doctor if you or the child are exposed to chickenpox when using Enbrel. 
Norice: Povejte zdravniku, če ste bili vi ali otrok med zdravljenjem z zdravilom Enbrel izpostavljeni noricam.
8 MYCLIC pre-filled pens 8 alcohol swabs 
8 napolnjenih injekcijskih peresnikov MYCLIC 8 alkoholnih blazinic
• With the needle still in the vial, hold the vial upside down at eye level. 
Ko je igla še vedno v viali, dvignite vialo tako, da bo obrnjena na glavo, približno v višini oči.
CARTON TEXT - EU/1/99/126/003-005 
BESEDILO NA NALEPKI VIALE - EU/1/99/126/003-005
Women using Enbrel should not breast-feed, since Enbrel passes into human breast milk. 
Zdravilo Enbrel prehaja v materino mleko, zato bolnice med zdravljenjem z zdravilom Enbrel ne smejo dojiti.
The three recommended injection sites for Enbrel using a pre-filled syringe include: (1) the front of the middle thighs; (2) the abdomen, except for the 5 cm area right around the navel; and (3) the outer area of the upper arms (see Diagram 1). 
Za injiciranje napolnjene injekcijske brizge zdravila Enbrel so priporočljiva tri injekcijska mesta: (1) na sredini sprednjega dela stegna; (2) na trebuhu, razen v predelu 5 cm okrog popka; in (3) na zunanjem delu nadlakti (glejte sliko 1).
By looking though the inspection window, the solution should be clear to slightly opalescent, colourless to pale yellow or pale brown and may contain small translucent or white particles of protein. 
Pri pogledu skozi okence za pregledovanje mora biti raztopina bistra do rahlo opalescentna, brezbarvna do bledo rumena oziroma bledo rjava ter lahko vsebuje majhne prosojne ali bele delce beljakovine.
• With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram 10). 
S hitrim in kratkim gibom potisnite iglo do konca v kožo pod kotom 45 do 90 stopinj (glejte sliko 10).
A careful risk/benefit evaluation, including a neurologic assessment, is recommended when prescribing Enbrel to patients with pre-existing or recent onset of demyelinating disease, or to those who are considered to have an increased risk of developing demyelinating disease. 
Pri bolnikih z demielinizirajočimi obolenji, ki so obstajala že prej ali so nastopila pred kratkim, ali pri tistih, ki imajo povečano tveganje za razvoj demielinizirajoče bolezni, je treba pred zdravljenjem z zdravilom Enbrel skrbno pretehtati tveganja in koristi, vključno z nevrološko oceno.
CARTON TEXT - EU/1/99/126/022 (For paediatric use) 
BESEDILO NA ŠKATLI - EU/1/99/126/022 (za uporabo pri otrocih)
Enbrel should not be used if all the powder in the vial is not dissolved within 10 minutes. 
Zdravila Enbrel ne smete uporabiti, če se ves prašek v viali ne raztopi v 10 minutah; v tem primeru to vialo zavrzite in vzemite novo.
Do not mix the Enbrel solution with any other medicine. 
Raztopine zdravila Enbrel ne smete mešati z nobenim drugim zdravilom.
Congestive heart failure (Cardiac failure congestive) Physicians should use caution when using Enbrel in patients who have congestive heart failure (CHF). 
Zdravniki morajo biti previdni, kadar predpišejo zdravilo Enbrel bolnikom s kongestivnim srčnim popuščanjem (KSP).
Dosing for adult patients (aged 18 years or over) Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis including ankylosing spondylitis The usual dose is 25 mg given twice a week or 50 mg once a week as an injection under the skin. 
Psoriatični artritis, ankilozirajoči spondilitis in radiografsko nezaznavni aksialni spondilartritis Priporočeni odmerek je 25 mg zdravila Enbrel dvakrat na teden ali 50 mg enkrat na teden.
Enbrel 25 mg is supplied as a white powder and solvent for solution for injection (powder for injection). 
Zdravilo Enbrel 25 mg je na voljo v obliki belega praška in vehikla za raztopino za injiciranje (prašek za injekcijo).
Using the MYCLIC pre-filled pen to inject Enbrel 
Uporaba napolnjenega injekcijskega peresnika MYCLIC za injiciranje zdravila Enbrel
Enbrel 50 mg solution for injection in pre-filled syringe Clear glass syringe (type I glass) with stainless steel needle, rubber needle cover and plastic plunger. 
Enbrel 50 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Injekcijska brizga iz prozornega stekla (steklo tipa I) z iglo iz nerjavečega jekla, gumijastim pokrovčkom igle in plastičnim batom.
The types and proportion of adverse events in juvenile idiopathic arthritis patients were similar to those seen in trials of Enbrel in adult patients with rheumatoid arthritis, and the majority were mild. 
Neželeni učinki pri bolnikih z juvenilnim idiopatskim artritisom so bili po vrstah in deležih podobni tistim, opisanim v preskušanjih zdravila Enbrel pri odraslih bolnikih z revmatoidnim artritisom.
Look for the needle tip inside the stopper window (see Diagram 3). 
Skozi okence v zamašku preverite, ali vidite konico igle (glejte sliko 3).
CARTON TEXT - EU/1/99/126/016-018 (50 mg Pre-filled Syringe) 
BESEDILO NA ŠKATLI - EU/1/99/126/016-018 (50 mg napolnjena injekcijska brizga)
• The three recommended injection sites for Enbrel include: (1) the front of the middle thighs; (2) the abdomen, except for the 5 cm area right around the navel; and (3) the outer area of the upper arms (see Diagram 17). 
Za injiciranje zdravila Enbrel so priporočljiva tri injekcijska mesta: (1) na sredini sprednjega dela stegna; (2) na trebuhu, razen v predelu 5 cm okrog popka; in (3) na zunanjem delu nadlakti (glejte sliko 17).
• Feeling nervous or anxious, throbbing sensations, sudden reddening of the skin and/or a warm feeling 
težave pri požiranju ali dihanju; otekanje obraza, žrela, rok ali nog; občutek živčnosti ali tesnobe, utripajoč občutek, nenadna pordelost kože in/ali občutek toplote;
• The three recommended injection sites for Enbrel include: (1) the front of the middle thighs; (2) the abdomen, except for the 5 cm area right around the navel; and (3) the outer area of the upper arms (see Diagram 9). 
Za injiciranje zdravila Enbrel so priporočljiva tri injekcijska mesta: (1) na sredini sprednjega dela stegna; (2) na trebuhu, razen v predelu 5 cm okrog popka; in (3) na zunanjem delu nadlakti (glejte sliko 9).
After preparing the Enbrel solution, immediate use is recommended. 
Priporočljivo je, da pripravljeno raztopino zdravila Enbrel nemudoma uporabite.
Enbrel 25 mg solution for injection in pre-filled syringe Enbrel is supplied as a pre-filled syringe containing a clear, colourless to pale yellow or pale brown solution for injection (solution for injection). 
Enbrel 25 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Zdravilo Enbrel je na voljo v napolnjeni injekcijski brizgi, ki vsebuje bistro, brezbarvno do bledo rumeno oziroma bledo rjavo raztopino za injiciranje (raztopino za injiciranje).
The following instructions explain how to prepare and inject Enbrel. 
V tem navodilu sta opisana priprava in dajanje injekcij zdravila Enbrel.
Enbrel 25 mg solution for injection in pre-filled syringe Clear glass syringe (type I glass) with stainless steel needle, rubber needle cover and plastic plunger. 
Enbrel 25 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Injekcijska brizga iz prozornega stekla (steklo tipa I) z iglo iz nerjavečega jekla, gumijastim pokrovčkom igle in plastičnim batom.
CARTON TEXT - EU/1/99/126/013-015, EU/1/99/126/026 (25 mg Pre-filled Syringe) 
BESEDILO NA ŠKATLI - EU/1/99/126/013-015, EU/1/99/126/026 (25 mg napolnjena injekcijska brizga)
• Congestive heart failure: Tell your doctor if the child has a history of congestive heart failure, because Enbrel needs to be used with caution under these circumstances. 
Kongestivno srčno popuščanje: Povejte zdravniku, če se je pri otroku kdaj pojavilo kongestivno srčno popuščanje.
• Leave the syringe in place. 
Brizgo pustite v viali.
• Chickenpox: Tell your doctor if the child is exposed to chickenpox when using Enbrel. 
Norice: Povejte zdravniku, če je bil otrok med zdravljenjem z zdravilom Enbrel izpostavljen noricam.
Common ≥ 1/100 to 
Pogosti ≥ 1/100 do < 1/10
Enbrel 50 mg solution for injection in pre-filled syringe Enbrel is supplied as a pre-filled syringe containing a clear, colourless to pale yellow or pale brown solution for injection (solution for injection). 
Enbrel 50 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Zdravilo Enbrel je na voljo v napolnjeni injekcijski brizgi, ki vsebuje bistro, brezbarvno do bledo rumeno oziroma bledo rjavo raztopino za injiciranje (raztopino za injiciranje).
Do not use this medicine after the expiry date which is stated on the carton and on the MYCLIC prefilled pen after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini in na napolnjenem injekcijskem peresniku MYCLIC poleg oznake ''Uporabno do'' ali ''Upor.
Detailed instructions on how to inject Enbrel are provided in section 7, “Using the MYCLIC pre-filled pen to inject Enbrel”. 
Podrobna navodila o injiciranju zdravila Enbrel so v poglavju 7 “Uporaba napolnjenega injekcijskega peresnika MYCLIC za injiciranje zdravila Enbrel”.
Powder: Mannitol, sucrose and trometamol. 
Pomožne snovi v zdravilu Enbrel so: prašek: manitol, saharoza in trometamol.
Doses of 25 mg of Enbrel (based on dose-finding studies in patients with rheumatoid arthritis) or placebo were administered subcutaneously twice a week for 6 months in 138 patients. 
138 bolnikov je prejemalo 25 mg odmerke zdravila Enbrel (na podlagi študij za ugotovitev odmerkov pri bolnikih z revmatoidnim artritisom) ali placeba subkutano dvakrat na teden 6 mesecev.
Do not use this medicine after the expiry date which is stated on the carton and the label after “EXP”. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in nalepki poleg oznake ''Uporabno do'' ali ''Upor.
Step 1: Preparing for an Enbrel injection 1. 
Korak 1: Priprava na injiciranje zdravila Enbrel
12b 
6. mesec b
The Enbrel pre-filled pen is available in 25 mg and 50 mg strengths. 
Napolnjena injekcijska brizga je na voljo v jakostih 25 mg in 50 mg.
Methotrexate 
Odmerjanje
• Congestive heart failure: Tell your doctor if you or the child have a history of congestive heart failure, because Enbrel needs to be used with caution under these circumstances. 
Kongestivno srčno popuščanje: Povejte zdravniku, če se je pri vas ali otroku kdaj pojavilo kongestivno srčno popuščanje.
Contact your doctor before using Enbrel if the needle cap will be handled by, or Enbrel will be given to, someone with a known or possible hypersensitivity (allergy) to latex. 
Če bo s pokrovčkom igle rokovala ali zdravilo Enbrel dobivala oseba z znano ali možno preobčutljivostjo (alergijo) na lateks, se pred uporabo zdravila Enbrel posvetujte z zdravnikom.
Enbrel is reconstituted with 1 ml water for injections before use and administered by subcutaneous injection. 
Pred uporabo in subkutanim injiciranjem zdravilo Enbrel rekonstituirajte v 1 ml vode za injekcije.
Talk to your doctor before taking Enbrel. 
Pred začetkom uporabe zdravila Enbrel se posvetujte z zdravnikom.
Comprehensive instructions for administration are given in the package leaflet, section 7, "Using the MYCLIC pre-filled pen to inject Enbrel." 
Obsežna navodila za aplikacijo so navedena v navodilu za uporabo, poglavje 7 "Uporaba napolnjenega injekcijskega peresnika MYCLIC za injiciranje zdravila Enbrel".
In a fourth study, the safety and efficacy of 50 mg Enbrel (two 25 mg SC injections) administered once weekly vs 25 mg Enbrel administered twice weekly were evaluated in a double-blind, placebocontrolled study of 356 patients with active ankylosing spondylitis. 
V četrti, dvojno slepi in s placebom nadzorovani študiji so pri 356 bolnikih z aktivnim ankilozirajočim spondilitisom vrednotili varnost in učinkovitost dajanja zdravila Enbrel v odmerku 50 mg enkrat na teden (dve 25 mg subkutani injekciji) v primerjavi z dajanjem zdravila Enbrel v odmerku 25 mg dvakrat na teden.
Pairwise comparison p-values: * = p < 0.05 for comparisons of Enbrel vs. methotrexate, † = p < 0.05 for comparisons of Enbrel + methotrexate vs. methotrexate and φ = p < 0.05 for comparisons of Enbrel + methotrexate vs. Enbrel. 
Vrednosti p za primerjavo po parih: * = p < 0,05 za primerjavo zdravila Enbrel z metotreksatom, † = p < 0,05 za primerjavo kombinacije zdravilo Enbrel + metotreksat z metotreksatom in  = p < 0,05 za primerjavo kombinacije zdravilo Enbrel + metotreksat z zdravilom Enbrel.
Contents of the pack and other information Instructions for preparing and giving an injection of Enbrel (See overleaf) 
Navodila za pripravo in dajanje injekcije zdravila Enbrel (glejte drugo stran navodila)
Cases of active tuberculosis including miliary tuberculosis and tuberculosis with extra-pulmonary location have been reported in patients treated with Enbrel. 
Pri bolnikih, zdravljenih z zdravilom Enbrel, so poročali o primerih aktivne tuberkuloze, vključno z miliarno tuberkulozo in ekstrapulmonarno tuberkulozo.
Each vial of Enbrel contains 10 mg etanercept. 
Ena viala zdravila Enbrel vsebuje 10 mg etanercepta.
Enbrel 25 mg powder for solution for injection 
Enbrel 25 mg prašek za raztopino za injiciranje
Contents of the pack and other information Using the MYCLIC pre-filled pen to inject Enbrel (See overleaf) 
Uporaba napolnjenega injekcijskega peresnika MYCLIC za injiciranje zdravila Enbrel (glejte drugo stran navodila)
EU/1/99/126/013 4 pre-filled syringes EU/1/99/126/014 8 pre-filled syringes EU/1/99/126/015 24 pre-filled syringes EU/1/99/126/026 12 pre-filled syringes 
EU/1/99/126/013 4 napolnjene injekcijske brizge EU/1/99/126/014 8 napolnjenih injekcijskih brizg EU/1/99/126/015 24 napolnjenih injekcijskih brizg EU/1/99/126/026 12 napolnjenih injekcijskih brizg
Each vial of Enbrel 10 mg should be used on a single occasion in a single patient, and the remainder of the vial should be discarded. 
Ena viala z zdravilom Enbrel 10 mg je namenjena za enkratno uporabo pri enem bolniku.
EU/1/99/126/016 2 pre-filled syringes EU/1/99/126/017 4 pre-filled syringes EU/1/99/126/018 12 pre-filled syringes 
EU/1/99/126/016 2 napolnjeni injekcijski brizgi EU/1/99/126/017 4 napolnjene injekcijske brizge EU/1/99/126/018 12 napolnjenih injekcijskih brizg
Tell your doctor if you or the child develop any change in the appearance of the skin or growths on the skin. 
Pri nekaterih bolnikih, ki so prejemali zdravilo Enbrel, se je pojavil kožni rak. Povejte zdravniku, če se pri vas ali otroku razvije kakšna sprememba videza kože ali rašče na koži.
Serious adverse reactions have also been reported for Enbrel. 
Pri uporabi zdravila Enbrel so poročali tudi o pojavu resnih neželenih učinkov.
CARTON TEXT - EU/1/99/126/023-025 (25 mg Pre-filled Pen) 
BESEDILO NA ŠKATLI - EU/1/99/126/023-025 (25 mg napolnjeni injekcijski peresnik)
9c 
6. mesec c
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS TEXT FOR SYRINGE LABEL - EU/1/99/126/003-005 
BESEDILO NA NALEPKI NAPOLNJENE INJEKCIJSKE BRIZGE - EU/1/99/126/003-005
28b a: p<0.001, Enbrel vs. placebo b: p = 0.002, Enbrel vs. placebo 
ASAS 70 2 tedna 3 meseci 6 mesecev b a: p < 0,001, zdravilo Enbrel proti placebu b: p = 0,002, zdravilo Enbrel proti placebu
Enbrel 25 mg injection etanercept 
Enbrel 25 mg injekcija etanercept subkutana uporaba
Purple needle safety shield 
beli pokrovček igle vijolični varnostni ščit igle
Each vial of Enbrel 25 mg contains 25 mg of etanercept. 
Ena viala zdravila Enbrel 25 mg vsebuje 25 mg etanercepta.
• Allergic reactions: If you or the child experience allergic reactions such as chest tightness, wheezing, dizziness or rash, do not inject more Enbrel, and contact your doctor immediately. 
Alergijske reakcije: Če se pri vas ali otroku pojavijo alergijske reakcije, na primer tiščanje v prsnem košu, piskajoče dihanje, omotica ali izpuščaj, prenehajte injicirati zdravilo Enbrel in nemudoma obvestite zdravnika.
Preparing the injection site and injecting the Enbrel solution 
Priprava mesta injiciranja in injiciranje raztopine zdravila Enbrel
The recommended dose is 25 mg Enbrel administered twice weekly, or 50 mg administered once weekly. 
Priporočeni odmerek je 25 mg zdravila Enbrel dvakrat na teden ali 50 mg enkrat na teden.
Cartons contain 4, 8, 12 or 24 pre-filled syringes of Enbrel and 4, 8, 12 or 24 alcohol swabs. 
Škatle vsebujejo 4, 8, 12 ali 24 napolnjenih injekcijskih brizg zdravila Enbrel in 4, 8, 12 ali 24 alkoholnih blazinic.
Inflammatory bowel disease (IBD) and uveitis in patients with juvenile idiopathic arthritis (JIA) There have been reports of IBD and uveitis in JIA patients being treated with Enbrel (see section 4.8). 
Kronična vnetna črevesna bolezen (KVČB): Pri bolnikih z juvenilnim idiopatskim artritisom (JIA), ki so se zdravili z zdravilom Enbrel, so poročali o primerih KVČB.
25 mg Enbrel administered twice weekly is the recommended dose. 
Priporočeni odmerek je 25 mg zdravila Enbrel dvakrat na teden.
• Allergic reactions: If the child experiences allergic reactions such as chest tightness, wheezing, dizziness or rash, do not inject more Enbrel, and contact your doctor immediately. 
Alergijske reakcije: Če se pri otroku pojavijo alergijske reakcije, na primer tiščanje v prsnem košu, piskajoče dihanje, omotica ali izpuščaj, prenehajte injicirati zdravilo Enbrel in nemudoma obvestite zdravnika.
CARTON TEXT - EU/1/99/126/019-021 (50 mg Pre-filled Pen) 
BESEDILO NA ŠKATLI - EU/1/99/126/019-021 (50 mg napolnjeni injekcijski peresnik)
• You will also need the following items: A sterile syringe and needle(s) of 25 gauge x 16 mm or similar A vial or ampoule of water for injections 2 alcohol swabs 
sterilno injekcijsko brizgo in iglo(e) velikosti 25 x 16 mm ali podobno,
Preparing the injection site and injecting the Enbrel solution h. Disposing of supplies a. 
Priprava mesta injiciranja in injiciranje raztopine zdravila Enbrel h.
Enbrel 50 mg solution for injection in pre-filled syringe The active substance in Enbrel is etanercept. 
Enbrel 50 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Učinkovina zdravila Enbrel je etanercept.
If you or the child experience allergic reactions such as chest tightness, wheezing, dizziness or rash, do not inject more Enbrel, and contact your doctor immediately. 
Če se pri vas ali otroku pojavi alergijska reakcija, npr. tiščanje v prsnem košu, piskajoče dihanje, omotica ali izpuščaj, prenehajte injicirati zdravilo Enbrel in nemudoma obvestite zdravnika.
Enbrel 25 mg solution for injection in pre-filled syringe Enbrel 50 mg solution for injection in pre-filled syringe 
Enbrel 25 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku Enbrel 50 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku
Enbrel 25 mg solution for injection in pre-filled syringe The active substance in Enbrel is etanercept. 
Enbrel 25 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Učinkovina zdravila Enbrel je etanercept.
The solution should be clear and colourless to pale yellow or pale brown, with no lumps, flakes, or particles. 
Raztopina mora biti bistra in brezbarvna do bledo rumena oziroma bledo rjava ter ne sme vsebovati kepic, kosmičev ali delcev.
If the child experiences allergic reactions such as chest tightness, wheezing, dizziness or rash, do not inject more Enbrel, and contact your doctor immediately. 
Če se pri otroku pojavi alergijska reakcija, npr. tiščanje v prsnem košu, piskajoče dihanje, omotica ali izpuščaj, prenehajte injicirati zdravilo Enbrel in nemudoma obvestite zdravnika.
Each pack contains 4, 8, 12 or 24 pre-filled syringes and 4, 8, 12 or 24 alcohol swabs. 
Eno pakiranje vsebuje 4, 8, 12 ali 24 napolnjenih injekcijskih brizg in 4, 8, 12 ali 24 alkoholnih blazinic.
Pairwise comparison p-values: † = p < 0.05 for comparisons of Enbrel + methotrexate vs methotrexate and φ = p < 0.05 for comparisons of Enbrel + methotrexate vs Enbrel 
Vrednosti p za primerjavo po parih: † = p < 0,05 za primerjavo kombinacije zdravila Enbrel + metotreksat z metotreksatom in  = p < 0,05 za primerjavo kombinacije zdravila Enbrel + metotreksat z zdravilom Enbrel.
Enbrel 25 mg solution for injection in pre-filled syringe EU/1/99/126/013 
Enbrel 25 mg raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/99/126/013
Enbrel 25 mg solution for injection in pre-filled syringe Each pre-filled syringe contains 25 mg of etanercept. 
Enbrel 25 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 25 mg etanercepta.
See section 5 for instructions on how to store Enbrel. 
Za navodila o shranjevanju zdravila Enbrel glejte poglavje 5.
These include the alcohol swab from the Enbrel carton and a cotton ball or gauze. 
Pripravite si še druge stvari, ki jih boste potrebovali pri injiciranju, to sta alkoholna blazinica iz škatle z zdravilom Enbrel in košček vate ali gaze.
Enbrel 50 mg solution for injection in pre-filled syringe EU/1/99/126/016 
Enbrel 50 mg raztopina za injiciranje v napolnjeni injekcijski brizgi EU/1/99/126/016
Tell your doctor if the child develops any change in the appearance of the skin or growths on the skin. 
Pri nekaterih bolnikih, ki so prejemali zdravilo Enbrel, se je pojavil kožni rak. Povejte zdravniku, če se pri otroku razvije kakšna sprememba videza kože ali rašče na koži.
Enbrel 50 mg solution for injection in pre-filled syringe Each pre-filled syringe contains 50 mg of etanercept. 
Enbrel 50 mg raztopina za injiciranje v napolnjeni injekcijski brizgi Ena napolnjena injekcijska brizga vsebuje 50 mg etanercepta.
Enbrel 25 mg powder for solution for injection Etanercept 
Enbrel 25 mg prašek za raztopino za injiciranje etanercept
Detailed instructions on how to prepare and inject Enbrel are provided in section 7, “Instructions for preparing and giving an injection of Enbrel”. 
Podrobna navodila o pripravi in injiciranju zdravila Enbrel so v poglavju 7 “Navodila za pripravo in dajanje injekcije zdravila Enbrel”.
Comprehensive instructions for administration are given in the package leaflet, section 7, "Instructions for preparation and giving an injection of Enbrel." 
Obsežna navodila za aplikacijo so navedena v navodilu za uporabo, poglavje 7 "NAVODILA ZA PRIPRAVO IN DAJANJE INJEKCIJE ZDRAVILA ENBREL".